BioSpace News Archive

GxP manufacturing experts Jason Congdon and Shannon Chesterfield join Azzur Group to leader Philadelphia and San Diego consulting operations

Remotely controlled hospital wards may sound like something out of science fiction, but they’re already becoming reality, and an innovation that could save time and even lives during the COVID-19 pandemic.

Median Technologies (ALMDT)(Paris:ALMDT), The Imaging Phenomics Company®, announces today the results of a preliminary retrospective study on the evaluation of the severity of hepatic fibrosis in Non-Alcoholic Steatohepatitis (NASH) patients using a new imaging biomarker extracted from MRI/MRE images.

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) a company focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic, today announced, the closing of its previously announced underwritten public offering of 14,189,189 shares of common stock at a price to the public of $0.37 per share. Oragenics expects to receive gross proceeds of approximately $6.0 milli

OpSens Inc. (“OpSens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, is presenting at the Piper Sandler 32nd Annual Virtual Healthcare Conference,

KEY CAPITAL CORPORATION (OTC PINK:KCPC) advises that Key Biotec, a division of Key Capital, has entered into agreement with Immunitor group interests (“Immunitor”) to exclusively license its breakthrough and patented oral tableted platform vaccine and immunotherapeutic products for North, Central and South America (excluding Canada), the EU (excluding UK), Australia and New Zealand (the “Territory”).

Dragonfly Therapeutics, Inc. (“Dragonfly” or the “Company”), today announced Dr. Alex Lugovskoy has joined the Company as Chief Operating Officer, and that the Company has strengthened its Scientific Advisory Board with the addition of leading drug developer and clinician Dr. Rob Hershberg.

Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of energy-based aesthetic systems for practitioners worldwide, today announced that Dave Mowry, Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report third quarter 2020 financial results for the period ended September 30, 2020, following the close of the market on Thursday, December 3rd, 2020.

Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces fully optimized, high-affinity lead monoclonal antibodies (MAbs) against Claudin 18.2 (CLDN18.2), a structurally complex oncology target overexpressed on numerous solid tumors.